Test Price
2,800 AED✅ Home Collection Available
C7orf43 Gene Autism Genetic Test in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
Clinical Genetic Assessment Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited NGS Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation and genetic counseling.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
This Next‑Generation Sequencing (NGS) test analyzes the C7orf43 gene to identify pathogenic variants associated with autism spectrum disorder, providing precise molecular insight for accurate diagnosis and personalized management.
| Feature | Our Test (C7orf43 NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision | 99.9% diagnostic sensitivity for single nucleotide variants and small indels | ~99% sensitivity, limited to targeted regions |
| Methodology | NGS (Next‑Generation Sequencing), validated on Illumina platform | Capillary electrophoresis (Sanger) |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
“As a Consultant Medical Genetics specialist, I recognize that genetic testing for C7orf43 can illuminate important aspects of a child’s neurodevelopmental journey. Every result must be interpreted alongside a comprehensive clinical evaluation and family history; this test is a powerful tool, not a standalone verdict. Please continue all prescribed therapies and consult your specialist before any change.” – Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory & Pre-Test Requirements
- Contraindications: The test may be deferred in acutely febrile patients or those with active systemic infection, as stress may affect DNA integrity.
- Emergency Red Flags: If the individual experiences sudden loss of previously acquired skills, new‑onset seizures, severe behavioral regression, or acute neurological deterioration, seek immediate emergency medical evaluation at the nearest hospital. This test does not replace urgent clinical assessment.
- Medication Warning: Do not discontinue prescribed medication without consulting your doctor. Genetic results are not a basis for altering treatment plans without professional guidance.
- Pre-Test Requirement: A genetic counselling session to draw a pedigree chart of family members affected with C7orf43 gene autism, and a detailed clinical history are mandatory before sample collection.
Exclusion Criteria & Patient Safety Red Flags
- Invasive Testing: Hospital Extraction Only – Sample collection is conducted strictly within an accredited hospital facility if invasive procedures are required; mobile home phlebotomy is disabled for safety.
- Clinical Deterioration: Sudden loss of previously acquired skills, new‑onset seizures, severe behavioral regression, or acute neurological deterioration requires immediate emergency medical evaluation.
- Medication Continuity: Do not discontinue prescribed medication without consulting your doctor.
Patient FAQ & Clinical Guidance
1. What is the C7orf43 gene autism Genetic Test, and why is it ordered?
The C7orf43 NGS sequences the entire coding region of the C7orf43 gene to detect pathogenic variants linked to autism spectrum disorder, enabling precise molecular diagnosis when clinical symptoms are present.
2. How is the sample collected and what are the accepted specimen types?
A trained phlebotomist collects a venous blood sample or a dried blood spot on an FTA card during a scheduled home visit; extracted DNA from a prior sample is also accepted.
3. When will I receive the results and how are they interpreted?
Results are available within 3 to 4 weeks and are interpreted by a clinical geneticist, integrating variant classification (pathogenic, likely pathogenic, or variant of uncertain significance) with the patient’s clinical phenotype.
UAE Regulatory & Data Privacy Adherence
Regulatory Compliance: This service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent protocols adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability.
Data Privacy: All genetic data is encrypted and stored securely in UAE-based servers. Access is restricted to authorized clinical personnel only. Genetic testing of minors requires documented consent from a legal guardian.
Clinical & Logistical Metadata
| Test Name | C7orf43 Gene Autism Genetic Test (NGS) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Venous Whole Blood, Dried Blood Spot (FTA Card), or Extracted DNA |
| Methodology Used | Next‑Generation Sequencing (NGS) on Illumina Platform |
| ICD-10-CM Code | F84.0 (Autistic Disorder) |
| LOINC Code | 21636-1 (Sequence analysis of specific gene) |
| DHA Facility License & Address | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians